A centralized database tracking all lipochondrocyte therapy recipients, collecting data on treatment efficacy, lifestyle factors, and social contribution metrics. Access to therapy is prioritized based on a combination of medical need, age, health status, and perceived societal value, as determined by a government-appointed panel.